Author
Listed:
- Jan-Inge Bjune
(University of Bergen
University of Bergen
Haukeland University Hospital)
- Samantha Laber
(Harwell Campus)
- Laurence Lawrence-Archer
(University of Bergen
Haukeland University Hospital)
- Patrizia M. C. Nothnagel
(University of Oslo)
- Shuntaro Yamada
(University of Bergen)
- Xu Zhao
(University of Oslo)
- Pouda Panahandeh Strømland
(Haukeland University Hospital)
- Niyaz Al-Sharabi
(University of Bergen)
- Kamal Mustafa
(University of Bergen)
- Pål R. Njølstad
(University of Bergen
Haukeland University Hospital)
- Melina Claussnitzer
(University of Bergen
Broad Institute of MIT and Harvard
Massachusetts General Hospital
Harvard Medical School)
- Roger D. Cox
(Harwell Campus)
- Pierre Chymkowitch
(University of Oslo)
- Gunnar Mellgren
(University of Bergen
University of Bergen
Haukeland University Hospital)
- Simon N. Dankel
(University of Bergen
University of Bergen
Haukeland University Hospital)
Abstract
IRX3 is linked to predisposition to obesity through the FTO locus and is upregulated during early adipogenesis in risk-allele carriers, shifting adipocyte fate toward fat storage. However, how this elevated IRX3 expression influences later developmental stages remains unclear. Here we show that IRX3 regulates adipocyte fate by modulating epigenetic reprogramming. ChIP-sequencing in preadipocytes identifies over 300 IRX3 binding sites, predominantly at promoters of genes involved in SUMOylation and chromatin remodeling. IRX3 knockout alters expression of SUMO pathway genes, increases global SUMOylation, and inhibits PPARγ activity and adipogenesis. Pharmacological SUMOylation inhibition rescues these effects. IRX3 KO also reduces SUMO occupancy at Wnt-related genes, enhancing Wnt signaling and promoting osteogenic fate in 3D cultures. This fate switch is partially reversible by SUMOylation inhibition. We identify IRX3 as a key transcriptional regulator of epigenetic programs, acting upstream of SUMOylation to maintain mesenchymal identity and support adipogenesis while suppressing osteogenesis in mouse embryonic fibroblasts.
Suggested Citation
Jan-Inge Bjune & Samantha Laber & Laurence Lawrence-Archer & Patrizia M. C. Nothnagel & Shuntaro Yamada & Xu Zhao & Pouda Panahandeh Strømland & Niyaz Al-Sharabi & Kamal Mustafa & Pål R. Njølstad & Me, 2025.
"IRX3 controls a SUMOylation-dependent differentiation switch in adipocyte precursor cells,"
Nature Communications, Nature, vol. 16(1), pages 1-25, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62361-1
DOI: 10.1038/s41467-025-62361-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62361-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.